Biohaven (BHVN) Change in Accured Expenses (2021 - 2026)

Biohaven has reported Change in Accured Expenses for 6 years, with the latest figure at -$64.4 million in Q1 2026.

• Quarterly Change in Accured Expenses fell 2415.38% year-over-year to -$64.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$63.0 million (down 3880.55% YoY) and the FY2025 annual result came in at $4.2 million, down 47.73% from the prior year.
• Change in Accured Expenses eased to -$64.4 million in Q1 2026 per BHVN's latest filing, from -$12.8 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $33.1 million in Q2 2022 and troughed at -$64.4 million in Q1 2026.
• A 5-year average of -$3.1 million and a median of $2.8 million in 2025 frame the typical range for Change in Accured Expenses.
• The sharpest annual moves came in 2025 and 2026: Change in Accured Expenses jumped 222.96% in 2025, then slumped 2415.38% in 2026.
• Over 5 years, Change in Accured Expenses stood at $18.7 million in 2022, then slumped by 172.34% to -$13.5 million in 2023, then increased by 6.61% to -$12.6 million in 2024, then declined by 1.26% to -$12.8 million in 2025, then slumped by 403.55% to -$64.4 million in 2026.
• According to Business Quant data, Change in Accured Expenses over the past three periods registered -$64.4 million, -$12.8 million, and -$7.4 million for Q1 2026, Q4 2025, and Q3 2025 respectively.